Brown Advisory’s Ascendis Pharma ASND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $5.04M | Sell |
|
|||||
|
2025
Q2 | $4.4M | Sell |
|
|||||
|
2025
Q1 | $4.03M | Sell |
|
|||||
|
2024
Q4 | $5M | Sell |
|
|||||
|
2024
Q3 | $69.8M | Sell |
|
|||||
|
2024
Q2 | $65.3M | Sell |
|
|||||
|
2024
Q1 | $103M | Buy |
|
|||||
|
2023
Q4 | $63.7M | Sell |
|
|||||
|
2023
Q3 | $47.8M | Buy |
|
|||||
|
2023
Q2 | $44.3M | Buy |
|
|||||
|
2023
Q1 | $50M | Buy |
|
|||||
|
2022
Q4 | $53.8M | Sell |
|
|||||
|
2022
Q3 | $65.9M | Sell |
|
|||||
|
2022
Q2 | $60.7M | Buy |
|
|||||
|
2022
Q1 | $61M | Buy |
|
|||||
|
2021
Q4 | $64.1M | Buy |
|
|||||
|
2021
Q3 | $67.1M | Buy |
|
|||||
|
2021
Q2 | $54.3M | Buy |
|
|||||
|
2021
Q1 | $39M | Buy |
|
|||||
|
2020
Q4 | $7.79M | Buy |
|
|||||
|
2020
Q3 | $5.93M | Buy |
|
|||||
|
2020
Q2 | $3.47M | Buy |
|
|||||
|
2019
Q2 | – | Sell |
|
|||||
|
2019
Q1 | $732K | Buy |
|